JPX · 9340.T
ASO International, Inc.
¥787-¥3 (-0.38%)
ASO International, Inc.’s quoted price sits in the upper half of its reported 52-week range, 7.08% below the high.
Loading market information…
JPX · 4582.T · JPY
Stock price, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
SymBio Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 80.79% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
SymBio Pharmaceuticals Limited’s next earnings report is currently expected on Feb 11, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow SymBio Pharmaceuticals Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:32 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥787-¥3 (-0.38%)
ASO International, Inc.’s quoted price sits in the upper half of its reported 52-week range, 7.08% below the high.
¥27-¥1 (-3.57%)
Solasia Pharma K.K.’s quoted price sits in the lower half of its reported 52-week range, 35.71% below the high.
¥18+¥1 (+5.88%)
OncoTherapy Science, Inc.’s quoted price sits in the lower half of its reported 52-week range, 47.06% below the high.
¥2,550-¥11 (-0.43%)
WDB coco Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 9.73% below the high.
¥559-¥5 (-0.89%)
Cyfuse Biomedical K.K.’s quoted price sits in the lower half of its reported 52-week range, 26.83% below the high.
¥1,515¥0 (0.0%)
Nippon Chemiphar Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.42% below the high.
¥132+¥2 (+1.54%)
PRISM BioLab Co.,LTD’s quoted price sits in the lower half of its reported 52-week range, 52.69% below the high.
¥47-¥1 (-2.08%)
MedRx Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 65.44% below the high.
